Kamyar Afshar, DO
Disclosures: GlaxoSmithKline-Salary-wife is an employee
UCSD Academic Biography and Bibliography

Current Review Eff:

 

 

 

UCSD ACADEMIC PERSONAL DATA

(for Appointment files only)

(Feb. 2018)

 

 

 

 

Name:

Last, First, Middle

AFSHAR, KAMYAR

Department

Medicine / Pulmonary Critical Care and Sleep Medicine

Title(s)

HS Associate Clinical Professor (proposed)

 

 

Business Address:

Street

9300 Campus Point Drive

Phone:

(858) 657-1869

City, State, Zip

La Jolla, CA 20037

Mail Code

7376

 

 

 

 

 

 

Home Address:

Street

11331 Longshore Court

Phone:

818-445-8986

City, State, Zip

San Diego, CA 92130

E-mail address:

kaafshar@ucsd.edu

 

 

 

 

Country of Citizenship:

USA

 

Are you a citizen or permanent resident of the U.S.?

Yes

No

 

If no, what is your current Visa status?

 

 

Date this status began:

 

 

Date this status expires:

 

 

 

 

 

Person to be contacted in case of emergency:

Name

Parastoo Rezai

Street

11331 Longshore Court

Phone:

323-823-2135

City, State, Zip

San Diego, CA 92130

 

 

 

 

 

Family members or domestic partners employed by the University:

Name

 

Relationship

 

Department

 

 


UCSD ACADEMIC BIOGRAPHY/BIBLIOGRAPHY FORM

 

 

 

Name:

Last, First, Middle

AFSHAR, KAMYAR

Department

Medicine / Pulmonary Critical Care and Sleep Medicine

Title(s)

HS Associate Clinical Professor (proposed)

 

Section I:  Employment History and Education

 

Previous Applicable Employment

 

Please provide a full account of your time from the date of your first academic (or otherwise relevant) employment to the present, including any periods when you were not employed. Indicate part-time appointments. Please include all previous University of California employment. You may provide supplementary information if necessary.

 

Period of employment

  From:                To:

Institution, firm or organization

Location

Rank, title, or position

07/2008 – 03/2015

04/2015 – 08/2015

09/2015 04/2018

University of Southern California

University of Southern California

University of California

Los Angeles, CA

Los Angeles, CA

San Diego

Assistant Professor

Associate Professor

Associate Physician; (MSP Contract); Clinical Instructor

05/2018 – Present

University of California

San Diego, CA

(HS) Associate Professor

 

 

Education

 

School, college, university, or hospital (internship, residency, or fellowship)

Dates of attendance

Location

Major subject or field

Degrees or certificates

Date received

University of California

 

 

Midwestern University

 

University of Southern California

 

University of Southern California

 

University of Southern California

 

University of Southern California

 

 

 

1998 - 2002

 

06/2002 – 06/2003

 

 

06/2003 – 06/2005

 

 

07/2005 – 06/2008

 

 

2007-2008

San Diego

 

 

Glendale, AZ

 

Los Angeles, CA

 

 

Los Angeles

 

 

Los Angeles

 

 

Los Angeles

Biochemistry and Cell Biology

 

Osteopathic Medicine

 

Categorical internal medicine

 

Categorical internal medicine

 

Pulmonary, Critical Care Medicine

 

 

BS

 

 

DO

 

Internship

 

 

Residency

 

 

Fellowship

 

 

Research Fellow

 

1997

 

 

2002

 

6/2003

 

 

6/2005

 

 

6/2008

 

 

2008

 

Please indicate areas of sub-specialization or board certification, if any. Also include a list of special licenses or permits and the dates received.

 

Medical Licence: California, Lic # 20A8875, issued 06/24/04; exp 08/31/2020

Diplomat, ABIM Specialty Internal Medicine 2005

Diplomat, ABIM Specialty in Pulmonary Disease 2007

Dilomat, ABIM Specialty in Critical Care 2008

 

 

Section II:  Professional Data

Please list your activities in each of the following eight categories.  Please provide dates of awards or service.

 

 

(a)    University Service (Include service at the departmental, college, Academic Senate, campuswide, and systemwide levels.)

 

 

Lung Transplant Operations Committee, Member January 2019 - present

 

Solid Organ Transplant Quality Committee, Member August 2018 - present

 

Lung Transplant Patient Selection Committee, Member September 2015 - present

 

Hospital Quality Council, Member  January 2019 present

 

LifeSharing Medical Advisory Committee, Member September 2015 - present

 

 

 

 
 
 
 

 

 

 

 

(b)Memberships (Include scholarly societies, professional boards, civic organizations, etc.)

 

American Society for Transplantation, Member 2017 - present

 

International Society of Heart and Lung Transplant, Member 2007-present

Pulmonary Transplantation Council

Pulmonary Infectious Disease Council

 

American Thoracic Society, Associate Member  2006 – present

Assembly of Clinical Problems

Assembly of Critical Care

 

American Lung Association (Breathe LA), Member  2006 - present

California Thoracic Society, Member  2006 – present

Trudeau Society of Los Angeles, Member 2008

Academy of Persian Physicians, Member 2009

American Osteopathic Association, Member 2008

 

(c)  Honors and Awards (Include the dates they were received.)

 

Provost Honors Roll

University of California at San Diego

La Jolla, CA  1996 – 1997

 

National Key Honors Society, 1997

 

Recognition of Service Award

Arizona Osteopathic Medical Association

Phoenix, AZ 2000-2001

 

Recognition of Service Award

National Student Osteopathic Medical Association

Philadelphia, PA 2001-2002

 

Resident of the Year

Department of Medicine

University of Southern California/Los Angeles County

Los Angeles, CA 2003-2004

 

Alpha Omega Alpha Honor Medical Society, Gamma Chapter

Keck School of Medicine-University of Southern California

Los Angeles, CA May 2004

 

Certificate of Merit

American College of Physicians Region I Chapter

Poster presentation regarding micronodular pattern for metastatic medullary thyroid cancer to the lungs

Los Angeles, CA April 4, 2004

 

Outstanding Teaching Award as a House Officer

Keck School of Medicine-University of Southern California

Los Angeles, CA August 2004

Medical Intensive Care Unit Fellow of the Year

University of Southern California/Los Angeles County

Los Angeles, CA 2005-2006

Southern California Pulmonary Research Symposium

Young Investigator Award, 2008

Palm Srings, CA

American College of Chest Physicians Leadership Development Award Recipient 2008

Marquis Who’s Who 2008

Academic Keys Who's Who in Medicine Higher Education (WWMHE) 2009

“America’s Top Physicians” 2009

Consumers’ Research Council of America

“America’s Top Physicians” 2010

Consumers’ Research Council of America

Pasadena Magazine 2011 - 2014 “Top Doc”

 

San Diego Magazine 2019 Top Doctor

 

 

(d)  Contracts and Grants (Provide the following information for current contracts and grants.)

 

Clinical trial history

 

Title

Granting agency

Amount of total award (include indirect costs)

Time period of contract/grant

Role (e.g. PI, co-investigator, project leader, etc.)

List co-PIs/corresponding share of total award (total must = 100%)

LIBERATE Study

PulmonX

 

7/2012 – 11/2022

 

Co-Investigator (site K Afshar; RG Barbers, PM McFadden): contribute in treatment of patients enrolled with severe emphysema (two groups of patients – treatment and control—who received Zephyr Endobronchial Valve (EBV) or optimal medical therapy alone, respectively; 190 patients

 

 

 

 

 

Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH).

University of Cincinnatti

 

11/2011-1/2018

Co-PI (K Afshar and B Baughman): assist in observation; prospective study (case-only) to characterize the demographics, clinical course, hemodynamics, pulmonary physiology and disease management of sarcoidosis associated pulmonary hypertension in the US; and compare to non-US sites

 

 

 

 

 

Evaluation of the effects of chronic rejection of lung allograft and Pneumocystis jiveroci colonization or infection.

Investigator-Initiated

 

10/2015 -present

 

Co-PI (K Afshar; A Morris): contribute clinical analysis of outcomes. This is an investigator initiated study to assess if the presence of PJP has a clinical impact on bronchiolitis obliterans syndrome. Bronchoalveolar fluid is obtained at the time of clinical indication for a bronchoscopy for lung transplant recipients. The BAL fluid obtained is analyzed for the presence of PJP by PCR method. The corresponding clinical information of the patients and their lung functions are corroborated to determine the effects of PJP on chronic allograft rejection

 

 

 

 

 

 

 

 

 

 

 

 

(e)                External Professional Activities  (Examples include, but are not limited to, technical service to organizations and agencies, acting as a reviewer of journal or book manuscripts or contract and grant proposals, or professional committee service.)

 

INVITED PRESENTATIONS: NATIONAL AND INTERNATIONAL

 

  1. Digestive Tract Carcinomas among Patients with Cystic Fibrosis following Lung and Kidney Transplantation. North American Cystic Fibrosis Conference. Anaheim,

      October 5, 2007

  1. Management of Sarcoidosis. California Thoracic Society. Carmel, California. February 2, 2008
  2. Recurrent Sarcoidosis in a Single Lung Transplant Allograft. 25th Annual Southern California Pulmonary Research Symposium. May  , 2008
  3. Pneumocystis Colonization in Lung Trasnplant Recipients. 25th Annual Southern California Pulmonary Research Symposium. May  , 2008
  4. Outcomes following Double Lung and Heart-Lung Transplantation for Pulmonary Hypertension: Analysis of UNOS Database. International Society for Heart and Lung Trasplantation Conference. Paris, France. April 2009
  5. Outcomes following Double Lung and Heart-Lung Transplantation for Pulmonary Hypertension: Analysis of UNOS Database. International Society for Heart and Lung Trasplantation Conference. Paris, France. April 2009
  6. Sarcoidosis: Treatment of Pulmonary and Extra-Pulmonary Disease. Interstitial Lung Disease and Pulmoary Hypertension: 2013 State of the Art for the Clinician. April 20, 2013 Cedars-Sinai Medical Center/Harvey Morse Conference Center, Los Angeles, CA
  7. Sarcoidosis Q&A. Sarcoidosis Network Foundation. April 27, 2013
  8. Minimizing Exacerbation Events for Individuals with COPD. American Academy of Persian Physicians. October 5, 2013
  9. Palliative Care in Adults with Cystic Fibrosis. North American Cystic Fibrosis Conference, Salt Lake City. October  17, 2013
  10. Palliative Care: “Mind, Body and Soul”. North American Cystic Fibrosis Conference, Salt Lake City. October  19, 2013
  11. Alpha-1 Lung and Liver Disease. Alpha-1 Education Days. Anaheim, CA. November 16, 2013
  12. Clinical Perspectives of COPD. 5th BREATHE LA COPD Conference: Improving fiscal and health impscts through accountable care. November 20, 2013
  13. Minimizing Exacerbation Events for Individuals with COPD. American Academy of Persian Physicians. October 5, 2013
  14. Palliative Care in Adults with Cystic Fibrosis. North American Cystic Fibrosis Conference, Salt Lake City. October  17, 2013
  15. Palliative Care: “Mind, Body and Soul”. North American Cystic Fibrosis Conference, Salt Lake City. October  19, 2013
  16. Alpha-1 Lung and Liver Disease. Alpha-1 Education Days. Anaheim, CA. November 16, 2013
  17. Clinical Perspectives of COPD. 5th BREATHE LA COPD Conference: Improving fiscal and health impscts through accountable care. November 20, 2013
  18. Still Coughing?! Non-resolving Pneumonia43rd Annual USC Diagnostics & Therapeutics Skills in Internal Medicine Conference. March 9, 2015 Hapuna Beach Prince Hotel, Hawaii
  19. ICU Management of the Lung Trasnplant Patient. 11th Annual Critical Care Conference. Annenberg Center for Health Sciences at Eisenhower Medical Center. June 6, 2015. Rancho Mirage, California
  20. Alpha-1 Antitrypsin Deficiency Lung Disease 101. Alpha-1 Foundation’s 24th Annual National Education Conference. July 24, 2015 Garden Grove, California
  21. The management of patients with CF in acute respiratory failure with non-invasive and invasive mechanical ventiation in the ICU Management. North American Cystic Fibrosis Conference, Orlando. October  28, 2016
  22. Men’s CF Sexuality North American Cystic Fibrosis Conference, Orlando. October  28,

2016

  1. Lung Transplant Policies and Procedures. 26th Annual National Education Conference. Alpha 1 Foundation. Chicago, IL June 25, 2017

 

 

 

INVITED PRESENTATIONS: LOCAL AND REGIONAL

 

 

  1. Digestive Tract Carcinomas among Patients with Cystic Fibrosis following Lung and Kidney Transplantation. North American Cystic Fibrosis Conference. Anaheim, CA. October 5, 2007
  2. Management of Sarcoidosis. California Thoracic Society. Carmel, California. February 2, 2008
  3. Pulmonary infections in Lung Transplant. USC Lung Transplant Conference December 5, 2008

 

  1. Recurrent Sarcoidosis in a Single Lung Transplant Allograft. 25th Annual Southern California Pulmonary Research Symposium. May  , 2008
  2. Pneumocystis Colonization in Lung Trasnplant Recipients. 25th Annual Southern California Pulmonary Research Symposium. May  , 2008
  3. Pulmonary infections in Lung Transplant. USC Lung Transplant Conference December 5, 2008
  4. Principles of Mechanical Ventilation. University of Southern California, Internal Medicine Grand Rounds January, 2009
  5. Ask the Doctor Session. USC Lung Transplant Support Group Meeting. April 7, 2009
  6. Post-Transplant Diabetes Mellitus. USC Lung Transplant Support Group Meeting. June 2, 2009
  7. Shock and Hemodynamic Monitoring I. USC Division of Pulmonary Critical Care Core Curriculum. July 29, 2009
  8. Post-Transplant Diabetes Mellitus. USC Lung Transplant Support Group Meeting. June 2, 2009
  9. Shock and Hemodynamic Monitoring I. USC Division of Pulmonary Critical Care Core Curriculum. July 29, 2009
  10. Shock and Hemodynamic Monitoring II. USC Division of Pulmonary Critical Care Core Curriculum. August 5, 2009
  11. Principles of Mechanical Ventilation. University of Southern California, Internal Medicine Grand Rounds January, 2009
  12. Ask the Doctor Session. USC Lung Transplant Support Group Meeting. April 7, 2009

 

  1. Pulmonary Hypertension---More Common Than You Think. USC Pulmonary Symposium: Pulmonary for the Non-Pulmonologist. June 6, 2009
  2. When Pneumonia Failes to Get Better. USC Pulmonary Symposium: Pulmonary for the Non-Pulmonologist. June 6, 2009
  3. CMV in Lung Transplant. USC Lung Transplant Conference November 6, 2009

 

  1. Shock and Hemodynamic Monitoring II. USC Division of Pulmonary Critical Care Core Curriculum. August 5, 2009
  2. Pulmonary Hypertension---More Common Than You Think. USC Pulmonary Symposium: Pulmonary for the Non-Pulmonologist. June 6, 2009
  3. When Pneumonia Failes to Get Better. USC Pulmonary Symposium: Pulmonary for the Non-Pulmonologist. June 6, 2009
  4. CMV in Lung Transplant. USC Lung Transplant Conference November 6, 2009
  5. Disseminated Acanthameba following Lung Transplantation. One Legacy. Loews Santa Monica. May 25, 2010
  6. Medical Complications following Lung Transplantation. USC Lung Transplant Conference. December 3, 2010
  7. Peri-operative Management of Lung Transplantation. USC Nursing. January 11, 2010
  8. Lung Transplant for Cystic Fibrosis. USC CF Education Day. May 22,2010
  9. Peri-operative Management of Lung Transplantation. USC Nursing. May 24, 2010
  10. Disseminated Acanthameba following Lung Transplantation. One Legacy. Loews Santa Monica. May 25, 2010
  11. Medical Complications following Lung Transplantation. USC Lung Transplant Conference. December 3, 2010
  12. New Treatment Algorithms for Cystic Fibrosis. USC Pulmonary Symposium 2011. June 4, 2011
  13. Medical Complications following Lung Transplantation: Patient Empowerment. USC Lung Transplant Patient Support Group. June 7, 2011
  14. Sarcoidosis: Treatment of Pulmonary and Extra-Pulmonary Disease. Interstitial Lung Disease and Pulmoary Hypertension: 2013 State of the Art for the Clinician. April 20, 2013 Cedars-Sinai Medical Center/Harvey Morse Conference Center, Los Angeles, CA
  15. Sarcoidosis Q&A. Sarcoidosis Network Foundation. April 27, 2013
  16. Multidisciplinary Rounding in the ICU: A how-to-guide. Verdugo Hills Hospital of USC. December 5, 2013
  17. USC Center for Advanced Lung Disease – 1 year update. Hospital Management Team. March 11, 2014
  18. USC Center for Advanced Lung Disease. Keck Medical Center of USC Guild. May 20, 2014
  19. Interstitial Lung Disease. August 27, 2014
  20. Alpha 1-antitrypsin deficiency. What’s in those Genes? USC Pulmonary Symposium; 2014 State of the Art. September 13, 2014 Westin, Pasadena
  21. Demystifying Office Spirometery. 43rd Annual USC Diagnostics & Therapeutics Skills in Internal Medicine Conference. March 9, 2015 Hapuna Beach Prince Hotel, Hawaii
  22. COPD Phenotypes: Diagnosis and Implications for Treatment. 43rd Annual USC Diagnostics & Therapeutics Skills in Internal Medicine Conference. March 10, 2015 Hapuna Beach Prince Hotel, Hawaii
  23. Smoking Cessation and Potential Pitfalls. 43rd Annual USC Diagnostics & Therapeutics Skills in Internal Medicine Conference. March 10, 2015 Hapuna Beach Prince Hotel, Hawaii
  24. Still Coughing?! Non-resolving Pneumonia43rd Annual USC Diagnostics & Therapeutics Skills in Internal Medicine Conference. March 9, 2015 Hapuna Beach Prince Hotel, Hawaii
  25. ICU Management of the Lung Trasnplant Patient. 11th Annual Critical Care Conference. Annenberg Center for Health Sciences at Eisenhower Medical Center. June 6, 2015. Rancho Mirage, California
  26. Alpha-1 Antitrypsin Deficiency Lung Disease 101. Alpha-1 Foundation’s 24th Annual National Education Conference. July 24, 2015 Garden Grove, California
  27. Living with chronic lung disease. American Lung Association. UCSD campus. October 29, 2015
  28. Indications for Lung Tranplant. Scripps La Jolla, November 3, 2015
  29. Alpha 1-Antitrypsin Deficiency and Lung Transplant. Alpha 1 Patient Symposium. UC San Diego. February 13, 2016
  30. Pulmonary Complications following Cardiac Surgery. 12th Annual Critical Care Conference. Annenberg Center for Health Sciences at Eisenhower Medical Center. June 3, 2017. Rancho Mirage, California
  31. Alpha 1-Antitrypsin Deficiency and Lung Transplant. Alpha 1 Patient Symposium. UC San Diego. December 8, 2018
  32. Differentiating Sarcoidosis from IPF. 1st Annual UCSD Advanced Lung Disedase Symposium. June 1, 2019
  33. Lung Transplantation for Alpha-1 Antitrypsin Deficiency. 1st Annual UCSD Advanced Lung Disedase Symposium. June 1, 2019

 

 

Editorships (ad hoc/current)

Editor, OMB Transplantation

 

Editor, Austin Journal of Pulmonary and Respiratory Medicine

 

Editorial Consultant, Physicans’ Information and Education Resource (PIER) by the American College of Physicans

 

Contributing Editor, American Medical Journal

 

Contributing Editor, Journal of Pulmonary and Respiratory Medicine

 

Contributing Editor, Journal of Emergency Medicine and Surgical Care

Guest Editor, Current Respiratory Medicine Reviews. The thematic issue: Advanced Lung Diseases: Breathing New Life in Complex Diseases

 

Editor, eBook series, “Frontiers in Open Surgery”. Bentham Science Publishers

Journal Reviews

2019    Associate Manuscript Reviewer

            Transplantation

            OMB Transplantation

2018    Associate Manuscript Reviewer

            OMB Transplantation

2017    Associate Manuscript Reviewer

            OMB Transplantation

2015              Case Reports in Obstetrics and Gynecology

              The Clinical Respiratory Journal

2014              Journal of Emergency Medicine and Surgical Care

              British Journal of Medicine and Medical Research

2013              Associate Manuscript Reviewer

              Journal of Intensive Care Unit

2012              Associate Manuscript Reviewer

              J Pulm Respir Med

              American Medical Journal

2011              Associate Manuscript Reviewer

              Journal of Transplantation

              Annals of Transplantation

              Journal of National Medical Association

2010              Associate Manuscript Reviewer

              Mycopathologia

              Journal of National Medical Association

2009              Associate Manuscript Reviewer

              Journal of National Medical Association

              Journal of Intensive Care Medicine

              International Journal of COPD

2008              Associate Manuscript Reviewer

              Journal of Respiratory Diseases

2007              Associate Manuscript Reviewer

              Cancer Therapy

2006              Associate Manuscript Reviewer

              Journal of National Medical Association

 

Abstract Reviews

2010              Society Critical Care Medicine. 40th Critical Care Congress, San Diego, California, USA

 

Consultantships

Pfizer Promotional Speaker Program - 2008

   Guidepoint Global – 2008

Grofols Speakers Bureau – 2014-2016

   Boerhinger-Ingelheim – 2015

   CSL Behring – 2015-2016

   Genentech – 2015-2016

 

Working Groups

Chair, Alpha -1 Foundation’s Transplant Issues Working Group 2016 - present

NACFC Palliative Care Working Group

 

Panels

The Treatment in Sarcoidosis. Fifteenth Annual Sarcoidosis Awareness and Educational Conference. Sarcoidosis Network Foundation, Inc., Cerritos, CA. March 24, 2007

Cardiac Sarcoidosis. Sixteenth Annual Sarcoidosis Awareness and Educational Conference. Sarcoidosis Network Foundation, Inc. , Cerritos, CA. March 29, 2008

Alpha-1 Lung and Liver Disease. Alpha-1 Education Days. Anaheim, CA. November 16, 2013

 

Medical Advisor

Sarcoidosis Network Foundation, Inc

 

Course Director

 

 

 

(f)                Most Significant Contributions to Promoting Diversity  (Examples include, but are not limited to, developing strategies for the educational or professional advancement of students in underrepresented groups; contributions that promote equitable access to and diversity in education; and activities that promote recruitment, retention, and mentoring.)

 

 

 

(g)  Other Activities (List those that do not fit into categories a – f above, such as community service).

 

UCSD Leadership Duties

 

 

Medical Director

UCSD Lung Transplant Program

July 2019 - present

 

 

Medical Director for Quality

UCSD Lung Transplant Program

July 2016 - present

 

 

Medical Director

UCSD Center for Advanced Lung Disease

September 2015 – June 2018

University of California, San Diego

  • Co-Clinic Director for the LAM clinic
  • Clinic Director for the Alpha 1-antitrypsin clinic

 

 

Associate Director

UCSD Adult Cystic Fibrosis Program

September 2015 – January 2018

 

 

USC Leadership Duties:

 

Medical Director

USC Center for Advanced Lung Disease

April 2013 – August 2015

University of Southern California, Keck School of Medicine

  • Clinic Director for the LAM clinic
  • Clinic Director for the Alpha 1-antitrypsin clinic

 

 

Associate Medical Director

Adult Cystic Fibrosis Center

July 2008 – August 2015

Division of Pulmonary and Critical Care University of Southern California, Keck School of Medicine

 

 

 

Associate Program Director, Fellowship Training

July 2008 – March 2015

Division of Pulmonary and Critical Care University of Southern California, Keck School of Medicine

 

 

Director

Inpatient Services Adult Cystic Fibrosis Center

July 2010 – August 2015

University of Southern California, Keck School of Medicine

 

Medical Director

Neurosurgical and Medical Intensive Care Units

July 2010 – August 2015

University of Southern California, Keck School of Medicine

 

Medical Director

Pediatric Lung Transplant Program

Children’s Hospital Los Angeles

July 2011 – April 2012

 

Chief Fellow

2007-2008

Division of Pulmonary and Critical Care University of Southern California, Keck School of Medicine

 

 

 

INSTITUTIONAL COMMITTEE SERVICE:2009-2015

Faculty Interviewer, Office of Admissions, Keck School of Medicine, University of Southern California, Los Angeles, CA, 2004 – 2010

 

Thoracic Committee Member

2008-2012

 

Organ Procurment Improvement Committee

Member 2008-2012

 

USC SYMPOSIUM:

Program Committee USC Pulmonary Symposium 2011. Downtown Los Angeles Marriott (June 6, 2009)

USC Pulmonary Symposium 2011. Downtown Los Angeles Marriott (June 4, 2011)

 

7 South Redesign. Performance Improvement Committee. October 3, 2011

7 South Redesign. USC Quality Committee of the Governing Board. October 19, 2011

 

Clinical Focus:

Transplant Experience during fellowship training 2006 – 2008

University of Southern California [8 months]

Stanford University Medical Center [3 months]

References: David Weill, MD; Gundeep Dhillon, MD

Cystic Fibrosis and non-CF Bronchiectasis (2007 - present)

COPD/Alpha 1-antitrypsin deficincey

Interstitial Lung Disease

Sarcoidosis

Rare Lung Diseases – LAM, TSC

Lung Transplantation

 

 

Professional Organizations

OneLegacy (Organ Procurement Oranization) (2008 - present)

 

Media Consultant (2008-2010)

 

What Doctors Know Magazine: About CF (Cystic Fibrosis). www.Whatdoctorsknow.com

 

Grey’s Anatomy – storyline on cystic fibrosis patients and lung transplantation

Reference: Christine Lee Program Assistant

Hollywood, Health & Society, USC Annenberg Norman Lear Center

8383 Wilshire Blvd., Suite 650, Beverly Hills, CA 90211

Email: leechris@usc.edu t: 323-782-3323 | f: 323-782-3320

 

Army Wives – storyline on a family having a child with cystic fibrosis

Reference: Sylvia Estafan Program Specialist

Hollywood, Health & Society, USC Annenberg Norman Lear Center

8383 Wilshire Blvd., Suite 650, Beverly Hills, CA 90211

Email: estafan@usc.edu t: 323-782-3325 | f: 323-782-3320

 

Royal Pains – storyline on a person with a rare presenation with sarcoidosis

Reference: Armine Kourouyan, MPH Program Specialist

Hollywood, Health & Society, USC Annenberg Norman Lear Center

8383 Wilshire Blvd., Suite 650, Beverly Hills, CA 90211

Email: akourouy@usc.edu t: 323.782.3314 | f: 323.782.3320 

 

 

 

(h)              Student Instructional Activities

 

Course load information is reported separately in faculty review files.  Please list here all students mentored outside of the structured classroom setting.  Please list by category (e.g., undergraduate research students, masters or doctoral candidates, postdoctoral or medical fellows, interns, residents) and indicate your role (e.g., thesis adviser, research adviser) for each student. For graduate students, indicate the years of their degrees when appropriate.

 

Student

ROLE

Interaction

(Research or Clinical)

Type of mentee (i.e. Postdoc, Clinical Fellow, Visiting Grad

Raju Reddy, MD

Mentor

Clinical

Fellow

S. Clark Berngard, MD

Mentor

Clinical

Fellow

Ian Britton, MD

Mentor

Clinical & Research

Fellow

Christine Bojanowski, MD

Mentor

Clinical

Fellow

Eric Scholten, MD

Brandon Nokes

Mentor

Mentor

Clinical

Clinical

Fellow

Fellow

 

 

 

 

 

 

 

(i)      External Reviews of Primary Creative Work
 

List only significant, independent reviews of the work—e.g., independent reviews or feature articles appearing in journals or online venues, major newspapers, books, or catalogs.  Forms of review and venues may vary by department.  (Please do not include advertisements, brief mention of candidate’s name or work, event listings, minor blog chatter, or self-promotional or commercial items.) 

 

 

 

 
Section III - Bibliography

 

 

  1. PRIMARY PUBLISHED OR CREATIVE WORK

This section should include original peer-reviewed work that appears in the open literature and can be reasonably expected to be found in libraries outside UCSD, or an appropriately documented listing of creative endeavors such as performances or shows of artistic works.  In addition to published work, this section may include items that are “in press” (i.e., accepted for publication in final form) or formally “accepted” (i.e., the publisher’s binding acceptance of entire corpus has been received).  Such items should clearly indicate “in press” or “accepted” somewhere in the citation. Do not include items that have been submitted for consideration but have not yet been accepted.   Materials associated with items in this section should be submitted with the file.

 

 

 

 

  1. Original Research Articles
    1. * Hill C, Maxwell B, Boulate D, Haddad F, Ha R, Afshar K, Weill D, Dhilon G. Heart-lung vs. double lung transplantation for idiopathic pulmonary arterial hypertension. Clin Transplant 2015: doi: 10.1111/ctr.12628

 

  1. Editorial

 

  1. Afshar K. Time to Lung Transplantation: Lung Allocation Score and Other Factors. Editorial. J Pulm Resp Med 2012,2:e110
  2. Afshar K. Treatments based on phenotypic variants in chronic obstructive pulmonary disease. J Pul Respir Med 2013;3:4
  3. * Afshar K. Management strategies in sarcoidosis: Why short-term Prednisone monotherapy is simply not enough. J Pulm Respipr Med 2014;4:4
  4. Afshar K. Future Direction of Immunosuppression in Lung Transplantation. Curr opin Organ Transplant 2014;19: 583-590
  5. Afshar K, Golts, E. Extracorpeal Membrane Oxygneation Bridge to Lung Transplantation in Patients with Cystic Fibrosis. Austin J Pulm Respir Med 2015; 2:1032
  6. * Berngard SC, Afshar K. Idiopathic pulmonary fibrosis: past, present, future – a review from Talmadge King’s ATS 2016 presentation. J Thorac Dis 2016. 8: S559-561
  7. * Liang NC, Troung KT, Afshar K. Key management considerations in sarcoidosis from the American Thoracic Society 2016 Conference. J Thorac Dis 2016. 8: S569-572
  8. Nokes B, Afshar K. Adjunctive therapies in idiopathic pulmonary fibrosis – where do we stand? J Thorac Dis. 2019 Feb;11(2):357-360. doi: 10.21037/jtd.2018.11.131.

 

 

 

  1. Case Reports

 

      1. Afshar K, Mundi M. Medical Image: Tuberculosis Verrucosa Cutis. Mayo Clin Proc. December 2004; 79(12):1562
      2. Afshar K, Alalawi R, Boylen CT. Case report: Micronodular Pulmonary Pattern for Metastatic Medullary Thyroid Cancer. JNMA (Journal of National Medical Association) May 2007; 99(5): 575-577
      3. Afshar K, Boyd-King A, Sharma OP. Case report: Primary pleural coccidioidomycosis. Journal of Medical Case Reports 2008;2:291
      4. Afshar K, Engelfried K, Sharma OP. Sarcoidosis: A rare case of Kleine-Levin-Critchley Syndrome. Sarcoidosis Vasculitis and Diffuse Lung Diseases 2008;25:60-63
      5. Afshar K, Cunningham M, Barbers RG, McFadden M. Pericardial Constriction following Lung Transplantation. Ann Thorac Surg 2010; 90(4):1361-1363
      6. Afshar K, Patel V, Forrester K, Rao AP, Ganesh S. Use of Foscarnet Therapy for EBV-associated PTLD Following Lung Transplantation. Journal of Transplantation 2011, Article ID 919651
      7. Afshar K, BoydKing A, Ganesh S, Herrington C, McFadden PM.  Rapidly fatal disseminated acanthamoebiasis in a single lung transplant recipient. Ann Transplant 2013; 18:108-111
      8. Shigemitsu H, Saleh S, Sharma OP, Afshar K. Colonic sarcoidosis responds to methotrexate: A case report with review of literature. J Pulm Respipr Med 2013;3:148.
      9. * Afshar K, Ahoui A, Benitez DS, Rao AP. Catheter-associated venous thromboembolism in patients with cystic fibrosis. J Pulm Respir Med 2013;3:143
      10. Kakal K, Lubman R, Afshar K. Why dyspnea is not just dyspnea. ATS Clinical Cases 2014
      11. Afshar K, Walsma K, Hogarth K. Alpha 1-Antirypsin Deficiency: Rule It Out. ATS Clinical Pearls 2014

 

  1. Review

 

  1. Afshar K, Vucinic V, Sharma OP. Eosinophil cell: Pray tell us what to do! Invited review for Curr Opin of Pulm Med 2007; 13: 414-421
  2. Morris A, Wei K, Afshar K, Huang L. Epidemiology and Clinical Significance of Pneumocystis Colonization. J Infect Dis 2008;197:10-17
  3. Shigemitsu H and Afshar K. Nocturnal Asthma. Curr Opin of Pulm Med 2007 Jan;13(1):49-55
  4. Shigemitsu H and Afshar, K. Aspiration Pneumonia: Underdiagnosed and undertreated. Curr Opin of Pulm Med 2007;13(3):192-198
  5. Iyer S, Afshar K, Sharma OP. Peritoneal and pleural sarcoidosis an unusual association: review and clinical report. Curr Opin Pulm Med 2008;14:481-487
  6. Afshar K, BoydKing A; Sharma OP, Shigemitsu H. Gastric sarcoidosis and Review of the Literature. J Natl Med Assoc 2010;102:419-422
  7. Afshar K, Orjioke N, Whelan TM. Medical complications in lung transplant recipients with pulmonary fibrosis. J Pulm Respir Med 2013;3:145
  8. Afshar K, Sharma OP. Interstitial Lung Diseases: Trails and tribulations. Curr Opin Pulm Med 2008;14:427-433
  9. Afshar K, BoydKing A. Pharmacotherapy of systemic sclerosis: Focus on Bosentan. Clinical Medicine: Therapeutics 2009;1:253-262

 

 

 

  1. Book Chapters (Previously A.VI)
  1. Afshar K, Falk J, Chaux. Lung Transplantation: Perioperative Management and Principles. Medical Management of the Thoracic Surgery Patient. First edition. Elsevier Health Sciences, Phildelphia, PA, pp 329-334, September 2009
  2. Afshar K, Barbers R. Lung Transplant and Interstitial Lung Disease. Clinical Focus on Interstitial Lung Disease. First Edition, Jaypee Brothers Medical Publishing Ltd. New Dehli, India 2012, pp 436-451
  3. Afshar K. Syndromes of Hypersensitivity Pneumonitis. Clinical Focus on  Hypersensitivity Pneumonitis. First Edition, Jaypee Brothers Medical Publishing Ltd. New Dehli, India. 2012 pp 92-115
  4. Afshar K, Tchen Y. Creating a Culture of Collective Responsibility and
  5.                                         Accountability to Patient Care Using an Interdisciplinary Approach to Improve Hospital Acquired Infections. Integrating Quality and Strategic Planning in Health Care Organizations. Jones and Bartlett Learning, LLC. Burlington, MA. 2012 pp 249-251
  1.                                         Afshar K, Rao AP, McFadden PM. Pulmonary Complications following Solid Organ Transplantation. Lung Involvment in Non-Pulmonary Disorders.2012
  2.                                         Nokes B, Golts E, Afshar K. Lung Transplant for Interstitial Lung Diseases. Interstital Lung Diseases DOI:10.5772/intechopne.82722  2019

 

 

 

  1. OTHER WORK

This section should include other published or creative works that you wish to list to demonstrate scholarly activity. Materials associated with items in this section need not be submitted with the file.   If you believe that a work is particularly important, please discuss it in your personal statement.  Describe the activity, product, or outcomes and include metrics to demonstrate impact, value, or innovative qualities. The department may comment on work in this section as a basis for advancement.

 

 

 

  1. Abstracts (Previously B.II)

 

  1. Afshar K, Escalant P, Saleh S, Aye SS, Valdez K, Hodges T, Morris A. Pneumocystis Colonization in Lung Trasnplant Recipients. American Thoracic Society. Toronto, Canada. May, 2008.
  2. Afshar K, Yeboah J, Iyer S, Beringer P, Rao AP. Stratification of CF patients based on severity of airflow obstruction and body mass index with rate of hospitalization. North American Cystic Fibrosis Conference. Orlando, FL October, 2008
  3. Owens, HM, BoydKing A, Afshar K, Rao AP, Beringer P. The effects od doxycycline on sputum biomarkers of inflammation and airway remodeling in patients with cystic fibrosis. American College of Clinical Pharmacy. October 2009
  4. Afshar K, Weill D, Valentine V, Dhillon GS. Outcomes following Double Lung and Heart-Lung Transplantation for Pulmonary Hypertension: Analysis of UNOS Database (Abstract). The Journal of Heart and Lung Transplantation 2009;28:S310-S311
  5. Afshar K, Weill D, Valentine V, Dhillon GS. Outcomes following Double Lung and Heart-Lung Transplantation for Pulmonary Hypertension: Analysis of UNOS Database (Abstract). The Journal of Heart and Lung Transplantation 2009;28:S310-S311
  6. Low S, Benitez D, Evangelista L, Modi A, Ahoui A, Balekian A, Afshar K and Rao AP. Utilization of  a nutritional and psychological algorithm to improve BMI in patients with cystic fibrosis. North American Cystic Fibrosis Conference. Baltimore, MD October, 2010
  7. Iyer S, Afshar K, Beringer P, and Rao AP.The Effect of Scedosporium Apiospermum on Decline in FEV1 in Patients with Cystic Fibrosis. North American Cystic Fibrosis Conference. Baltimore, MD October, 2010
  8. Ahoui A; Rao AP; Fukushima L; Benitez D; Afshar K. Central Catheter Associated Thromboembolism in CF Patients. North American Cystic Fibrosis Conference. Anaheim, CA November, 2011
  9. Afshar K; Modi A, Gould MK; Yao L; Fukushima L; Rao AP. Outcomes of Adult CF Patients with Pandemic H1N1. North American Cystic Fibrosis Conference. Anaheim, CA November, 2011
  10. Rakhshan E; Fukushima L; Benitez D; Borok Z; Rao AP; Afshar K. Quality improvement: Role of pre printed orders. North American Cystic Fibrosis Conference. Anaheim, CA November, 2011
  11. Orjioke N; Yao L; Gould MK; Rao AP, Afshar K, McFadden PM. Predictors of Morbidity in the first year following LungTransplantation in Patients with Cystic Fibrosis. CHEST 2011;140:461A
  12. Benitez D; Fukushima L; Delgado E; Afshar K; Rao AP. I’m Late, I’m Late for a Very Important Date: A Patient Satisfaction Survey of the Mobilaire Compressor. North American Cystic Fibrosis Conference. Anaheim, CA November, 2011
  13. Fukushima L; Evangelista L; Rao AP; Afshar K. Do Adults with Cystic Fibrosis have Neurocognitive Impairment? North American Cystic Fibrosis Conference. Anaheim, CA November, 2011
  14. Afshar K, Evangelista L, Balekian A, Fukushima L; Delgado E; Rao AP. Effects of Insurance, Income and Education in Patients with CF. North American Cystic Fibrosis Conference. Anaheim, CA November, 2011
  15. Kuo M, Rao AP, Afshar K. Outcomes and Predictors of Respiratory Failure requiring Mechanical Ventilation in Patients with Cystic Fibrosis. American Thoracic Society. San Francisco, CA May, 2012
  16. Fukushima LK, Evangelista L, Afshar K, Rao AP. Cognitive Dysfunction in Adult Cystic Fibrosis Patietns. American Thoracic Society. San Francisco, CA May, 2012
  17. Orjioke N, Wilcox A, McFadden PM, Herrington C, Afshar K. Evaluation of Airway Strictures following Lung Transplantation with CT Reconstruction: Comparison between Virtual and Fiberoptic Bronchoscopy. CHEST 2012;142:1097A
  18. Flora AS, Balekian A, Rao AP, Afshar K. The Effect of Fungal Colonization in Adults with Cystic Fibrosis. North American Cystic Fibrosis Conference. Orlando, FL November, 2012
  19. Patel P, Evangelista L, Chang S, Beringer P, Afshar K, Rao AP. Utilization of a nutrition and psychosocial algorithm to maintain goal body mass index in adult patients with cystic fibrosis. North American Cystic Fibrosis Conference. Orlando, FL November, 2012
  20. Iyer S, Afshar K, Evangelista L, Fukushima LK, Rao AP. Women’s health and sexuality: Important considerations for women with cystic fibrosis. North American Cystic Fibrosis Conference. Orlando, FL November, 2012
  21. Iyer S, Afshar K, Fukushima L, Evangelista L, Rao AP. Demystifying Sex: A gynecological view of women with cystic fibrosis. North American Cystic Fibrosis Conference. Orlando, FL November, 2012
  22. Afshar K, Fukushima, Modi A, Ahoui A, Balekian A, Rao AP. The utilization of the BODE index for cystic fibrosis patients. North American Cystic Fibrosis Conference. Orlando, FL November, 2012
  23. Mei N, Rao AP, McFadden PM, Afshar K. Maternal exposure to leflunomide in a cystic fibrosis lung transplant recipient. American Thoracic Society. Philadelphia, PA May, 2013 pA1293
  24. Afshar K, Fukushima LK, IyerKumar S, Ganesh S, Rao AP, Qiao R. Treatment of associated pulmonary hypertension in cystic fibrosis patients: Are there any deleterious effects? American Thoracic Society. Philadelphia, PA May, 2013 pA3300
  25. Mei N, Fukushima LK, Patel P, Rao AP, Afshar K. Phenotypic characteristics of cystic fibrosis patients with unilateral lung disease. American Thoracic Society. Philadelphia, PA May, 2013 pA4353
  26. Patel P, Fukushima LK, Lu A, Chou W, Rao AP, Afshar K. Menstruation in women with cystic fibrosis: Is there an effect on allergic bronchopulmonary aspergillosis? American Thoracic Society. Philadelphia, PA May, 2013 pA4352
  27. Ponnezhan V, Lu A, Rao AP, Afshar K. Reverse albumin/globulin ratio in cystic fibrosis patients: The signal or the noise for immunologically mediated complications. American Thoracic Society. Philadelphia, PA May, 2013 pA4354
  28. Kim N, Patel P, Fukushima L, Afshar K, Rao AP. Pulmonary exacerbations and modified BODE index in adults with cystic fibrosis. American Thoracic Society. San Diego, CA May, 2014
  29. Fukushima LK, Patel P, Afshar K, Rao AP, Hammond TC. Is rhino-sinustis in adult cystic fibrosis patients associated with altered sleep habits? American Thoracic Society. San Diego, CA May, 2014
  30. Fukushima L, Gonzalez M, Rao A, Afshar K. Alpha  1-antitrypsin deficiency carrier status in patients with cystic fibrosis. North American Cystic Fibrosis Conference. Phoenix, AZ  November, 2015
  31. Park J, Wilcox J, Rao A, Afshar K. Process evaluation of including an occupational therapist within a multidisciplinary CF care team. North American Cystic Fibrosis Conference. Phoenix, AZ  November, 2015
  32. Wilcox J, Park J, Rao A, Afshar K. Promoting healthy lifestyle through improving disease self-management. North American Cystic Fibrosis Conference. Phoenix, AZ  November, 2015
  33. Woo MS, Tummala S, Afshar K, Rao A, Woo MA, Fukushima L, Kumar R. Brain injury in healthy adult CF homozygous F508del patients. North American Cystic Fibrosis Conference. Phoenix, AZ  November, 2015
  34. Gonzalez M, Fukushima L, Rao A, Afshar K. Use of complementary and alternative medicine among adults with cystic fibrosis. North American Cystic Fibrosis Conference. Phoenix, AZ  November, 2015
  35. Woo MS, Roy B, Afshar K, Rao A, Fukushima L, Eshaghian P, Woo M, Kumar R. Neurophysiological, sleep and brain assessment in adult CF homozygous F508Del. A671
  36. Waldman G, Mariski M, Feist A, Awdishu L, Afshar K, Yung G. Prevalence of venous thromboembolic events in ILD lung transplant patients treated with sirolimus. ISHLT 2017, San Diego. A-2384
  37. Aslam S, Yung G, Dan J, Reed S, LeFebvre M, Logan C, Taplitz R, Law N, Golts E, Afshar K, Schooley R. Bacteriophage treatment in a lung transplant recipient: Safety and efficacy. ISHLT 2018, Nice, France.
  38. Burt C, Kozuch J, Maiski M, Feist A, Yung G, Floreth T, Golts E, Afshar K. Isavuconazonium pharmacokinetic interactions with immunosuppression in thoracic transplant recipients. ISHLT 2019 Orlando, Fl, USA
  39. Emtiazjoo AM, Chandrashekaran S, Pelaez A, Alnuaimat H, Shahmohammadi A, Machuca T, Pipkin M, Floreth T, Yung G, Golts E, Afshar K. Alpha 1-antitrypsin deficiency: Diagnossis and replacement in the lung transplant phase of life – survey among lung transplant specialists. ISHLT 2019 Orlando, Fl, USA
  40. Waldman G, Feist A, Yung G, Afshar K. Kidney function in lung transplant patients receiving IV tacrolimus. ISHLT 2019 Orlando, Fl, USA

 

 

 

  1. Additional Products of Major Research (Previously B.IV)

 

 

    1.                Afshar K, Baird S. Treatment Options (Clinical Pathways) of Esophageal Cancer 1996
    2.                Afshar K, Annual Cancer Report, Veterans Health Care Facility, San Diego 4/1996
    3.                Afshar, K. Patients Bill of Rights. Student Doctor Journal, Fall 2001 issue

 

 

 

 

 

  1. Posters (Previously B.V)

 

  1. Afshar K Micronodular pattern for metastatic medullary thyroid cancer to the lungs. American College of Physicians Region I Chapter, Los Angeles, CA. April 4,  2004
  2. Afshar K Acute GVHD following Lung Transplantation. International Society for Heart and Lung Transplantation. Chicago, IL April 2010.
  3. Afshar K Rapidly Fatal Disseminated Acanthamoebiasis in a Single Lung Tansplant Recipient. International Society for Heart and Lung Transplantation Prague, Czech Republic April, 2012
  4. Afshar K Association between Alpha 1-antitrypsin Deficiency and Sarcoidosis. American Thoracic Society. San Diego, CA May, 2014

 

 

 

 

  1. WORK IN PROGRESS

This section is optional and should include only items for which there is actual material that will be submitted with the file for review. This section is intended primarily for disciplines in which completion of scholarly work normally occurs over a lengthy period of time, and in which evidence of progress on a project is considered crucial for assessing a candidate’s accomplishments.  Such evidence might include chapters of a major book or documentation of progress on a major work of art. This section is particularly important for appraisals of assistant professors.  For other actions, use of the Work in Progress section is discouraged. 

 

When an item is moved from Section C to either Section A or B, it should be annotated accordingly (e.g., “from Work in Progress”). Work may also be removed from Section C if it has been abandoned and is no longer in progress, provided that it has been listed in this section for two consecutive review cycles. (It is listed as in progress at one review, as abandoned at the next, and is removed at the third).  Although a horizontal line should be used to indicate new items added, the items listed and the numbering scheme may be altered at each review, if necessary, and should be annotated accordingly.

 

 

 

 

 

 

 

 

I have provided the information contained in this Biography and Bibliography Form or have reviewed it for accuracy.

 

 

 

1/10/2020

Signature

 

Date